Why REPROMEDALab?
We follow the latest scientific knowledge in the field and are one of the first to put it into practice.
PRECONCEPTION GENETIC TESTING
Preconception testing is performed before conceiving. It enables the analysis of the genetic compatibility of partners and helps to adjust the treatment specifically for the couple.
PANDA Carrier
This genetic test is designed to detect hidden gene mutations in couples. The goal of such examination is to reduce the risk of birth of a child affected by the severe monogenic disease. Currently, we perform screening of 110 genes linked to clinically most relevant monogenic diseases.
PANDA Basic
This panel was developed at Repromeda clinic, tailored especially for patients who come with fertility issues, as well as for those trying to conceive naturally. This test completely replaced methods used in preconception genetic diagnosis previously.
PANDA Complete
The most comprehensive genetic compatibility test for couples. It combines the benefits of the ILGA and PANDA CARRIER tests, providing a detailed insight into factors affecting fertility and the reproductive health of the future child.
The ILGA test (Infertility-Linked Genotype Analysis) enables the examination of genes associated with infertility. In women, it can identify genetic factors affecting embryo implantation or oocyte maturation. In men, it focuses on genes linked to significant sperm analysis disorders.
EXOME
This genetic test is designed to detect hidden gene mutations in couples. The goal of such examination is to reduce the risk of birth of a child affected by the severe monogenic disease. Currently, we perform screening of 110 genes linked to clinically most relevant monogenic diseases.
KARYOTYPE
Each human cell normally contains 46 chromosomes. But human chromosomes also differ. Twenty-two of these are called autosomes, one from each mother’s and father’s pairs. There are also two sex chromosomes called gonosomes, which are responsible for sex determination.
PREIMPLANTATION GENETIC DIAGNOSIS
Preimplantation genetic testing is a method that allows the diagnosis and selection of a suitable embryo prior to its transfer into the uterus.
PGT-M: PREIMPLANTATION GENETIC TESTING FOR MONOGENIC DISORDERS
Currently we use the Karyomapping method. The examination is thus suitable both for all monogenic disorders and for hereditary cancer syndromes as well.
PGT-A: PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDIES
Preimplantation genetic testing for aneuploidies is performed during IVF treatment. It increases treatment success by selecting the most perspective embryo for transfer.
PGT-A Plus: ROZŠÍŘENÉ PREIMPLANTAČNÍ GENETICKÉ TESTOVÁNÍ ANEUPLOIDIÍ
PGT-A Plus je pokročilá metoda genetického vyšetření, která umožňuje detekci chromozomových aberací v embryu.
PGT-SR: PREIMPLANTATION GENETIC TESTING FOR STRUCTURAL CHROMOSOMAL REARRANGEMENTS
PGT of structural chromosomal rearrangements is suitable for couples where one or both partners are carriers of a balanced translocation or other structural chromosomal abnormality.
Liquid handling workstation Sciclone G3 NGS
To prepare sequencing libraries for preconception diagnostics and PGT-A, we use a modern automatic liquid handling workstation Sciclone G3 NGS, which not only significantly speeds up and simplifies the sample preparation process, but also helps us to achieve maximum accuracy and reliability of the whole process.
NON-INVASIVE PRE-IMPLANTATION SCREENING - EMBRYOSCREEN
Our genetic laboratory is the first and so far the only workplace in the Czech Republic that performs this method.
EmbryoScreen
EmbryoScreen ranks embryos by quality and their risk of chromosomal aberration (aneuploidy). The embryo with the highest potential is then selected for introduction into the uterus. This will increase the chances of the embryo nesting and achieving pregnancy upon the first transfer.
For whom the method is suitable?
For couples who are not indicated for PGT but want to increase their chances of getting pregnant during the first transfer.
What is the difference between PGT and EmbryoScreen?
With EmbryoScreen, it is not necessary to perform a biopsy on the embryo as is the case with PGT. Instead, our laboratory only analyses the DNA that is spontaneously released when the embryos are cultured. However, EmbryoScreen is not a substitute for PGT. If you are indicated for PGT, it is always better to use this test.
WHY REPROMEDALab?
We are both an IVF centre and a medical genetics clinic. Thanks to this, we know the needs of our customers well.